Health Canada Special Access Programme (SAP) Requests

The Health Canada Special Access Programme (SAP) allows practitioners to submit a request to Health Canada for access to a drug that is unavailable for sale in Canada. This access is limited to provision to patients with serious or life-threatening conditions on a compassionate or emergency basis when conventional therapies have failed, are unsuitable, or are unavailable.

Submission to CHIPER for review and approval in SAP circumstances is not required. Please see the CHIPER Policy on Health Canada Special Access Programme (SAP) Requests for additional details.